文献速递抗栓抗凝管理药物不良反应与药物警戒

药师主导的用药适宜性核查干预改善住院患者抗凝药物合理使用

Improving appropriate use of anticoagulants in hospitalised patients: A pharmacist-led Check of Medication Appropriateness intervention.
PubMed 文献 · Br J Clin Pharmacol · 2022-02-07

本研究在住院患者中实施药师主导的用药适宜性核查(CMA)干预,聚焦抗凝药物相关潜在不适当处方(PIP)。准实验间断时间序列分析显示,干预后每日残余PIP中位比例从78.5%降至18.2%,相对降低70%(95%CI 0.19-0.46),2年内提供2778条建议,接受率75.1%。

要点

  • 药师主导的CMA干预可显著减少抗凝药物相关残余PIP。
  • 干预后残余PIP中位比例由78.5%降至18.2%。
  • 2年期间建议接受率为75.1%。

核心结论

  • 药师主导的基于临床规则的CMA干预显著减少抗凝药物相关残余PIP,可能支持更安全的抗凝处方。

研究设计与样本

  • 准实验间断时间序列分析,比较干预前后抗凝药物相关PIP数量。
  • 干预前队列接受常规护理,干预后队列实施包含13条抗凝相关临床规则的CMA。
  • 干预前:36天内466例住院患者中观察到501例PIP;干预后:相同天数内485例患者中检测到538例PIP。

主要发现

  • 干预前每日残余PIP中位比例为78.5%(范围46.2%-100%)。
  • 干预后每日残余PIP中位比例降至18.2%(范围0-100%)。
  • 干预与抗凝相关残余PIP立即相对降低70%相关(95%CI 0.19-0.46)。
  • 干预后2年内提供2778条建议,接受率75.1%。

关键数值与推荐

  • 残余PIP定义为CMA干预后持续至48小时的PIP。
  • CMA包含13条与抗凝治疗相关的临床规则。

临床怎么用

  • 药师可基于临床规则开展抗凝药物适宜性核查,以减少潜在不适当处方。
  • 干预后建议接受率较高,提示药师建议在临床中具有可操作性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Inappropriate anticoagulant use increases the risk of bleeding and thrombotic events. We implemented clinical decision rules to promote judicious medication use, as part of the 'Check of Medication Appropriateness' (CMA). The CMA is a pharmacist-led review service, targeting potentially inappropriate prescriptions (PIPs). In this analysis, we aimed to evaluate the impact of the CMA on anticoagulant prescribing. METHODS: The number of anticoagulant-related PIPs was evaluated before and after implementation of the intervention in a quasi-experimental interrupted time series analysis. The pre-implementation cohort received usual care. The anticoagulant-focused CMA, comprising 13 clinical rules pertaining to anticoagulation therapies, was implemented in the post-implementation cohort. Segmented regression analysis was used to assess the impact of the intervention on the number of residual PIPs. A residual PIP was defined as a PIP which persisted up to 48 hours after the CMA intervention. Total number of recommendations and acceptance rate were documented for the 2-year post-implementation period. RESULTS: Pre-implementation, we observed 501 PIPs in 466 inpatients on 36 days, with a median proportion of 78.5% (range: 46.2%-100%) residual PIPs per day. Post-implementation, 538 PIPs were detected in 485 patients over the same number of days. The CMA intervention reduced the median proportion to 18.2% (range: 0-100%) per day. The effect coincided with an immediate relative reduction of 70% (95%CI 0.19-0.46) in anticoagulant-related residual PIPs. Post-implementation, 2778 recommendations were provided and 75.1% were accepted. CONCLUSION: Our CMA approach significantly reduced anticoagulant-related PIPs. Implementing a pharmacist-led intervention, based on clinical rules, may support safer prescribing of anticoagulants.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Quintens C, Verhamme P, Vanassche T, et al. Improving appropriate use of anticoagulants in hospitalised patients: A pharmacist-led Check of Medication Appropriateness intervention. Br J Clin Pharmacol. 2022. PMID: 34913184. doi:10.1111/bcp.15184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。